Adynxx Raises $16M

San Francisco-based Adynxx, a developer of therapeutics for treating chronic pain, said this week that it has raised $16M in a Series B funding round. The funding was led by TPG Biotech, and also included Domain Associates. TPG's Heath Lukatch has joined the board of Adynxx as part of the funding. More information »